Biofrontera AG - ADR
BFRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$131.05M
Close$
$3.26
22.3% upside
Current Fair Value
22.3% upsideUndervalued by 22.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $131.05 Million |
|---|---|
| Enterprise Value | $133.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.55 |
| Outstanding Shares | 28,358,692 |
Return
| Return on Equity | -106.87% |
|---|---|
| Return on Assets | -26.45% |
| Return on Invested Capital | -50.93% |
Valuation & Multiples
| P/E Ratio | -1.62 |
|---|---|
| PEG | 1.82 |
| Price to Sales | 2.67 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.9 |
| Enterprise Value to EBIT | -19.44 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 1.26 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biofrontera Inc
82 employees
CEO: Hermann Lübbert Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company off...